In an STZ-induced diabetic mouse trauma model, melatonin-pretreated exosomes derived from mesenchymal stem cells (MT-Exo) effectively inhibited the pro-inflammatory factors IL-1β and TNF-α, while the relative expression of anti-inflammatory factor IL-10 was increased. Here, TNF is linked to diabetes mellitus.